Besifloxacin Hydrochloride Patent Expiration
Besifloxacin Hydrochloride is Used for treating ocular bacterial infections. It was first introduced by Bausch And Lomb Inc
Besifloxacin Hydrochloride Patents
Given below is the list of patents protecting Besifloxacin Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Besivance | US8481526 | Fluoroquinolone carboxylic acid molecular crystals | Jan 09, 2031 | Bausch And Lomb |
| Besivance | US8415342 | Besifloxacin ophthalmic composition for the treatment or control of infection | Nov 07, 2030 | Bausch And Lomb |
| Besivance | US8604020 | Fluoroquinolone carboxylic acid molecular crystals | Mar 12, 2030 | Bausch And Lomb |
| Besivance | US8937062 | Compositions and methods for treating, reducing, ameliorating, or preventing infections caused by antibacterial drug-resistant bacteria | Nov 13, 2029 | Bausch And Lomb |
| Besivance | US6685958 | Quinolone carboxylic acid compositions and related methods of treatment |
Jun 29, 2021
(Expired) | Bausch And Lomb |
| Besivance | US6699492 | Quinolone carboxylic acid compositions and related methods of treatment |
Mar 31, 2019
(Expired) | Bausch And Lomb |
| Besivance | US5447926 | Quinolone carboxylic acid derivatives |
Apr 13, 2016
(Expired) | Bausch And Lomb |
Besifloxacin Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List